Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
ID: 358935Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358935
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) to enhance the research workforce in non-malignant kidney, urologic, and hematologic diseases. This funding opportunity invites applications for U2C-TL1 awards aimed at recruiting, training, and retaining researchers by providing coordinated support, resources, and networks, with a focus on establishing an Administrative Core, a Networking and Professional Development Core, and a TL1 Training Core that supports at least five pre- and/or post-doctoral trainees. The total estimated program funding is $4 million, with individual awards capped at $2.1 million, and applications are due by May 25, 2026, and May 25, 2027, with the final closing date for submissions set for May 26, 2028. For further inquiries, interested applicants can contact Tracy Rankin, Ph.D., at NIDDK_KUH@nih.gov.

    Point(s) of Contact
    NIDDK_KUH@nih.gov
    Files
    Title
    Posted
    PAR-26-115-Full-Announcement.html
    The Department of Health and Human Services, National Institutes of Health, and National Institute of Diabetes and Digestive and Kidney Diseases have reissued PAR-23-248 as PAR-26-115, an Institutional Network Award (U2C - Clinical Trial Not Allowed). This funding opportunity, titled "Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training," aims to bolster the research workforce in non-malignant kidney, urologic, and hematologic diseases. It invites applications for U2C-TL1 awards to recruit, train, and retain researchers by providing coordinated support, resources, and networks. The awards will establish an Administrative Core (U2C), a Networking and Professional Development Core (U2C), and a TL1 Training Core, which must support at least five pre- and/or post-doctoral trainees. The U2C costs cannot exceed 40% of the TL1 costs. Eligible applicants include various higher education institutions, nonprofits, and government entities, with a maximum project period of five years. Applications are due May 25, 2026, and May 25, 2027, with an expiration date of May 26, 2028.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Institutional Network Award aimed at promoting research training in kidney, urologic, and hematologic fields. This initiative seeks to support institutions in developing a robust network to engage and train the next generation of researchers through innovative outreach and career development activities, with each institution eligible to apply for a single award to support at least five trainee slots. The total estimated funding for this program is $4 million, with an award ceiling of $2.1 million, and the NIH anticipates making approximately eight awards. Interested applicants can reach out to Dr. Tracy Rankin at rankint@niddk.nih.gov or (301) 594-4748 for further information, with the estimated synopsis post date set for July 5, 2025, and applications expected to be solicited by October 5, 2025.
    Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY)." This initiative aims to establish a Coordinating Center that will unify and enhance various training and career development programs focused on recruiting, training, and retaining a national community of researchers in kidney, urologic, and hematologic diseases. The program is critical for fostering collaboration and innovation within these health fields, ultimately contributing to improved research outcomes. The estimated total funding for this cooperative agreement is $2,000,000, with one award expected to be made. Interested applicants can reach out to Christine Maric-Bilkan via email at christine.maric-bilkan@nih.gov for further information, with key deadlines including a synopsis close date of July 1, 2026, and an estimated project start date of February 1, 2027.
    Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed), aimed at supporting the KPMP cohort through the collection and de-identification of clinical data and samples. The project seeks to establish a Central Hub that will collaborate with various sites to evaluate kidney biopsies from participants with acute kidney injury or chronic kidney disease, ultimately creating a Kidney Tissue Atlas and identifying critical components for novel therapies. This cooperative agreement has an estimated total funding of $5 million, with one award expected, and applications are due by October 5, 2026. For further inquiries, interested applicants can contact Debbie S. Gipson at Debbie.Gipson@nih.gov or by phone at 301-480-2268.
    Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed), aimed at enrolling participants with acute kidney injury (AKI) and/or chronic kidney disease (CKD) into a longitudinal cohort study. The selected recruitment sites will collaborate with various entities to conduct protocol-based kidney biopsies, create a Kidney Tissue Atlas, and identify critical disease subgroups and therapeutic targets. This initiative is crucial for advancing kidney disease research and developing novel therapies, with an estimated total program funding of $4 million and an expected seven awards to be made. Interested applicants can reach out to Debbie S. Gipson, MS, MD at Debbie.Gipson@nih.gov or call 301-480-2268 for further information, with applications due by October 5, 2026, and project start anticipated on July 1, 2027.
    Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project (KPMP) - Tissue Interrogation Sites (TIS) through a cooperative agreement, aimed at analyzing human kidney tissue. The primary objective is to collaborate with various sites to obtain and evaluate kidney biopsies from participants suffering from acute kidney injury (AKI) or chronic kidney disease (CKD), ultimately creating a Kidney Tissue Atlas and identifying critical disease subgroups and therapeutic targets. This initiative is crucial for advancing kidney disease research and developing novel therapies, with an estimated total program funding of $6 million and an expected seven awards to be made. Interested applicants can reach out to Debbie S. Gipson at Debbie.Gipson@nih.gov or by phone at 301-480-2268, with applications due by October 5, 2026, and project start anticipated on July 1, 2027.
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Funding Opportunity titled "High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development of unique capabilities and resources to address critical gaps in clinical and translational science within awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs. The funding opportunity, numbered PAR-25-156, allows for project budgets of up to $500,000 per year over a project period of up to five years, with applications involving clinical trials being optional. Interested applicants, primarily from public and state-controlled institutions of higher education, must submit detailed integration plans, milestones, and sustainability evaluations by the closing date of September 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for a limited competition grant titled "Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers," which requires a clinical trial. This opportunity aims to extend the COPE-AKI clinical trial consortium for three years, focusing on meeting enrollment targets, completing participant follow-up, and facilitating data analysis to enhance clinical management strategies for patients recovering from acute kidney injury (AKI). The successful completion of this study is expected to inform the development of standard care practices for Stage 2 and 3 AKI survivors, addressing a significant gap in current healthcare. The estimated total program funding is $2.5 million, with three awards anticipated, and interested applicants can reach out to Ivonne Schulman at ivonne.schulman@nih.gov or by phone at 301-435-3350. Key deadlines include the synopsis posting on April 1, 2026, application closing on July 1, 2026, and the anticipated project start date on February 1, 2027.
    Limited Competition: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Field Epidemiology Sites
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Field Epidemiology Sites." This cooperative agreement aims to support the continuation of the CURE Consortium, which focuses on understanding the causes and potential interventions for Chronic Kidney Disease of Uncertain Etiology (CKDu) affecting agricultural communities, particularly in low and middle-income countries. The research is crucial as CKDu poses significant health risks, leading to kidney failure among young working-age populations, and the findings will have implications for kidney health in the U.S. The estimated total program funding is $6 million, with five awards expected, and applications are due by July 1, 2026. For further inquiries, interested parties can contact Susan Mendley at susan.mendley@nih.gov or by phone at 301.827.1861.
    Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required) under Funding Opportunity Number RFA-DK-26-308. This initiative aims to complete enrollment in the Liver Cirrhosis Network Cohort and the RESCU clinical studies, specifically targeting current grant recipients of RFA-DK-20-003, with a limit of one application per institution. The program is crucial for advancing clinical and translational research on cirrhosis treatments and outcomes, with the NIH planning to commit approximately $3.3 million in FY 2026 for up to ten awards, each with a maximum project period of five years. Applications are due by March 6, 2026, and interested parties can contact the Division of Digestive Diseases and Nutrition at NIDDKDDN@nih.gov for further information.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.